Advanced in Transient Global Amnesia

Nils Peters

UCL Queen Square Institute Of Neurology, 
London, ENG, GB 
Advanced in Transient Global Amnesia
UCL Queen Square Institute Of Neurology, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Nils Peters practices in London, United Kingdom. Mr. Peters is rated as an Advanced expert by MediFind in the treatment of Transient Global Amnesia. His top areas of expertise are Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, Stroke, Vascular Dementia, Thrombectomy, and Liver Embolization.

His clinical research consists of co-authoring 124 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Transient Global Amnesia.

Gender
Male

Locations

UCL Queen Square Institute Of Neurology, London, ENG, United Kingdom
Other Locations
Reichskanzler Müller Str. 23, Mannheim, BW 68165, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Phase: Not Applicable
Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist Oral Anticoagulants (NOAC) With Tranexamic Acid
Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist Oral Anticoagulants (NOAC) With Tranexamic Acid
Enrollment Status: Completed
Publish Date: April 04, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

124 Total Publications

Levodopa Added to Stroke Rehabilitation: The ESTREL Randomized Clinical Trial.
Levodopa Added to Stroke Rehabilitation: The ESTREL Randomized Clinical Trial.
Journal: JAMA
Published: September 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Peters's expertise for a condition
ConditionClose
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile